A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Clinical trial NCT05208762 · RECRUITING

Trial details

NCT number: NCT05208762
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Squamous Cell Carcinoma of the Head and Neck Esophageal Squamous Cell Carcinoma Triple Negative Breast Neoplasms Gastric Cancer Endometrial Cancer Pancreatic Adenocarcinoma Hepatocellular Carcinoma

Start date: 2022-10-25
Primary completion: 2028-01-05
Enrollment: 714

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.